Business Standard: August 16, 2016
New Delhi: In its attempt towards ease of doing business, the central government has relaxed norms for import and export of human biological samples.
A recent notification of the Union government stated that companies importing or exporting human biological samples for commercial or research purposes would not require import licences or export permits.
While the industry welcomed the move, some said this notification was just doing away with the paperwork. Revenues won't be impacted drastically, nor would it increase the number of samples into the country.
An official from Dr Lal Path Labs told Business Standard this would "lead to speedy transfer of samples for testing and improve the turn-around time for patients needing the results of diagnosis, thereby expediting the treatment process".
In an e-mail response to a query on the subject, Dr N Sathyabhama, director of Medical Services and Quality, southern region, Apollo Hospitals Enterprise Limited, said, "The policy will ensure quick and hassle-free processing of critical diagnostic samples and help patients get a treatment plan at the earliest."
Another industry source told Business Standard this notification would make companies more responsible because the onus will be on them to abide by the rules.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.